|
KIAA1107 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.184200E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.502400E-01 |
| Normal-vs-Stage2 |
4.359200E-01 |
| Normal-vs-Stage3 |
3.780200E-01 |
| Normal-vs-Stage4 |
8.445600E-01 |
| Stage1-vs-Stage2 |
4.913600E-01 |
| Stage1-vs-Stage3 |
2.959400E-01 |
| Stage1-vs-Stage4 |
7.012000E-01 |
| Stage2-vs-Stage3 |
1.991390E-01 |
| Stage2-vs-Stage4 |
5.146000E-01 |
| Stage3-vs-Stage4 |
7.855000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.416400E-01 |
| Normal-vs-AfricanAmerican |
6.911600E-01 |
| Normal-vs-Asian |
6.484800E-01 |
| Caucasian-vs-AfricanAmerican |
6.363000E-01 |
| Caucasian-vs-Asian |
1.659000E-01 |
| AfricanAmerican-vs-Asian |
4.084800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.321000E-01 |
| Normal-vs-Female |
2.832100E-02 |
| Male-vs-Female |
3.558000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.017400E-01 |
| Normal-vs-Extreme_Weight |
4.729600E-01 |
| Normal-vs-Obese |
3.092800E-01 |
| Normal-vs-Extreme_Obese |
7.547400E-01 |
| Normal_Weight-vs-Extreme_Weight |
2.366400E-01 |
| Normal_Weight-vs-Obese |
8.719200E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.846200E-01 |
| Extreme_Weight-vs-Obese |
1.240970E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.783800E-01 |
| Obese-vs-Extreme_Obese |
9.419800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.055000E-01 |
| Normal-vs-Age(41-60Yrs) |
3.049700E-02 |
| Normal-vs-Age(61-80Yrs) |
8.859800E-01 |
| Normal-vs-Age(81-100Yrs) |
4.684800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.409400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.261400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.031200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.858400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.123200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.589000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
8.016300E-02 |
| Normal-VS-Type2 PRCC |
2.735600E-01 |
| Normal-VS-KIRP CIMP |
6.069200E-01 |
| Normal-VS-Unclassified PRCC |
9.189600E-02 |
| Type1 PRCC-VS-Type2 PRCC |
1.241570E-02 |
| Type1 PRCC-VS-KIRP CIMP |
7.339800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.697400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.497400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.986080E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
3.118200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.822200E-01 |
| Normal-vs-N1 |
3.107600E-01 |
| Normal-vs-N2 |
4.229000E-01 |
| N0-vs-N1 |
1.060960E-01 |
| N0-vs-N2 |
8.605800E-01 |
| N1-vs-N2 |
4.368600E-01 |
|
|
